 |
Our Medical Technologies |
|
Due to our breakthrough new understandings of how the human genome
functions we have been able to develop many new and/or advanced health and medical
capabilities – and have many more in the pipeline. Our new understandings have primarily (and most importantly) resulted in us discovering a vast array of new metabolic networks, of which now also form the primary underpinnings of our Metabolic Amplification Platform Technology and related developments. Our Metabolic Amplification Platform Technology now serves as a highly versatile platform for allowing major advances in both the use of and the development of pharmaceutical, nutraceutical, phytoceutical and zooceutical products and services. As such, we are now in the process of developing new and/or advanced medical treatments for a wide range of illnesses. Furthermore to all of this, our core understandings are also being utilised to make major advances in many other biotechnology related applications. We have also been developing advanced hydrocolloids to help serve the growing concerns of resistant microbes whist also providing a safe and versatile product range for a wide array of general disinfectant, antiseptic and antibiotic applications. |
|
| .......................................... | |
| Members Area | |
| Retrieve Password | |
| Menu | |
 |
Introduction |
|
|
Our Newly Discovered Metabolic Networks |
|
|
Our Metabolic Amplification Platform Technology |
|
|
Nutraceutical Applications |
|
|
Pharmaceutical Applications |
|
|
Phytoceutical Applications |
|
|
Zooceutical Applications |
|
|
R & D Applications |
|
|
Diagnostic Applications |
|
|
Our Medical Treatments |
|
|
Advanced Hydrocolloids |
|
|
Partnering With Us |
|
|
Technology Pipeline |